Literature DB >> 28804632

The pattern of IL-24/mda-7 and its cognate receptors expression following activation of human hepatic stellate cells.

Iman Jamhiri1, Seyed Younes Hosseini2, Davood Mehrabani3, Zahra Khodabandeh3, Ramin Yaghobi4, Razieh Dowran2, Saber Zahri1.   

Abstract

Activation of hepatic stellate cells (HSCs) is the pivotal event during liver fibrosis. Interleukin (IL)-24/melanoma differentiation-associated gene-7 (mda-7) has attracted attention in the pathophysiology of some diseases, while its role in activation/suppression of human HSCs is still unclear. It is important to elucidate whether the expression levels of the IL-24/mda-7 protein and its receptors in HSC cells are changed following activation. LX-2 cells, a human hepatic stellate cell line were activated by a combination of leptin and serum starvation. The activation state was evaluated through measuring the mRNA expression of profibrotic molecules, collagen-I, TIMP metalloproteinase inhibitor-1 and transforming growth factor-β. The expression of IL-24/mda-7 was assessed in mRNA and protein levels by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and ELISA methods, respectively. Hence, the amount of IL-22R1 and IL-20R2 subunit expression was also compared in activated and normal LX-2 cells by RT-qPCR. The expression level of IL-24/mda-7 and its cognate receptors was detectable both in the normal and activated LX-2 cell line. Furthermore, in activated LX-2, a significant increase of IL24 expression either on IL-22R1 and IL-20R2 subunits was also noticeable in comparison to normal cells. The activation state of LX-2 cells caused significant changes of IL-24/mda-7 and its receptors expression. In addition, the elevation in IL-24/mda-7 during LX-2 cell activation, suggested that IL-24/mda-7 and its cognate receptors serve a possible role in the development of the fibrosis process. Therefore, IL-24/mda-7 and relevant signaling pathways may be employed as a target for fibrosis treatment.

Entities:  

Keywords:  IL-20R2; IL-22RI; IL-24/mda-7; LX-2; human hepatic stellate cells

Year:  2017        PMID: 28804632      PMCID: PMC5526037          DOI: 10.3892/br.2017.931

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  33 in total

1.  Leptin and liver fibrosis: a matter of fat.

Authors:  Fabio Marra
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Current and future anti-fibrotic therapies for chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

4.  IL-22 is involved in liver regeneration after hepatectomy.

Authors:  Xiaodan Ren; Bin Hu; Lisa M Colletti
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-29       Impact factor: 4.052

5.  Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells.

Authors:  Qi Cao; Ki M Mak; Charles S Lieber
Journal:  J Hepatol       Date:  2006-09-22       Impact factor: 25.083

6.  Oncolytic adenovirus-mediated MDA-7/IL-24 overexpression enhances antitumor activity in hepatocellular carcinoma cell lines.

Authors:  Chao-Wen Xiao; Xin-Bo Xue; Hui Zhang; Wei Gao; Yuan Yu; Kun Chen; Jian-Wei Zheng; Cong-Jun Wang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2010-12

7.  Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.

Authors:  E Y Huang; M T Madireddi; R V Gopalkrishnan; M Leszczyniecka; Z Su; I V Lebedeva; D Kang; H Jiang; J J Lin; D Alexandre; Y Chen; N Vozhilla; M X Mei; K A Christiansen; F Sivo; N I Goldstein; A B Mhashilkar; S Chada; E Huberman; S Pestka; P B Fisher
Journal:  Oncogene       Date:  2001-10-25       Impact factor: 9.867

Review 8.  Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  J Gastroenterol Hepatol       Date:  2007-06       Impact factor: 4.029

9.  T cell-derived microvesicles induce mast cell production of IL-24: relevance to inflammatory skin diseases.

Authors:  Irit Shefler; Metsada Pasmanik-Chor; Dvora Kidron; Yoseph A Mekori; Alon Y Hershko
Journal:  J Allergy Clin Immunol       Date:  2013-06-12       Impact factor: 10.793

10.  Liver Injury and the Activation of the Hepatic Myofibroblasts.

Authors:  Joy X Jiang; Natalie J Török
Journal:  Curr Pathobiol Rep       Date:  2013-09-01
View more
  3 in total

1.  Characterization of IL-19, -20, and -24 in acute and chronic kidney diseases reveals a pro-fibrotic role of IL-24.

Authors:  Domonkos Pap; Apor Veres-Székely; Beáta Szebeni; Réka Rokonay; Anna Ónody; Rita Lippai; István Márton Takács; András Tislér; Magdolna Kardos; Franz Oswald; Andrea Fekete; Attila J Szabó; Ádám Vannay
Journal:  J Transl Med       Date:  2020-04-19       Impact factor: 5.531

2.  The enhancing impact of amino termini of hepatitis C virus core protein on activation of hepatic stellate cells.

Authors:  Khashayar Shahin; Seyed Younes Hosseini; Hoshang Jamali; Mohammad-Hossein Karimi; Negar Azarpira; Mastaneh Zeraatian
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020

Review 3.  Interleukin-24 Immunobiology and Its Roles in Inflammatory Diseases.

Authors:  Yajie Zhong; Xuan Zhang; Waipo Chong
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.